vs
Side-by-side financial comparison of SS Innovations International, Inc. (SSII) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
SS Innovations International, Inc. is the larger business by last-quarter revenue ($14.5M vs $13.2M, roughly 1.1× TriSalus Life Sciences, Inc.). SS Innovations International, Inc. runs the higher net margin — -17.0% vs -73.9%, a 56.9% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs 59.8%). TriSalus Life Sciences, Inc. produced more free cash flow last quarter ($-2.5M vs $-3.2M). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs 43.0%).
SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
SSII vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.5M | $13.2M |
| Net Profit | $-2.5M | $-9.8M |
| Gross Margin | 43.9% | 86.7% |
| Operating Margin | -3.7% | -24.8% |
| Net Margin | -17.0% | -73.9% |
| Revenue YoY | 79.1% | 59.8% |
| Net Profit YoY | -28.5% | 3.5% |
| EPS (diluted) | $-0.01 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.5M | $13.2M | ||
| Q3 25 | $12.8M | $11.6M | ||
| Q2 25 | $10.0M | $11.2M | ||
| Q1 25 | $5.1M | $9.2M | ||
| Q4 24 | $8.1M | $8.3M | ||
| Q3 24 | $4.4M | $7.3M | ||
| Q2 24 | $4.5M | $7.4M | ||
| Q1 24 | $3.6M | $6.5M |
| Q4 25 | $-2.5M | $-9.8M | ||
| Q3 25 | $-3.7M | $-10.8M | ||
| Q2 25 | $-256.7K | $-8.3M | ||
| Q1 25 | $-5.7M | $-10.4M | ||
| Q4 24 | $-1.9M | $-10.1M | ||
| Q3 24 | $-3.2M | $-2.4M | ||
| Q2 24 | $-4.1M | $-4.3M | ||
| Q1 24 | $-9.8M | $-13.2M |
| Q4 25 | 43.9% | 86.7% | ||
| Q3 25 | 48.1% | 83.5% | ||
| Q2 25 | 59.1% | 83.9% | ||
| Q1 25 | 21.2% | 83.7% | ||
| Q4 24 | 48.9% | 85.3% | ||
| Q3 24 | 52.8% | 86.3% | ||
| Q2 24 | 31.9% | 87.6% | ||
| Q1 24 | 20.0% | 85.0% |
| Q4 25 | -3.7% | -24.8% | ||
| Q3 25 | -14.3% | -77.9% | ||
| Q2 25 | 1.0% | -65.4% | ||
| Q1 25 | -115.6% | -79.9% | ||
| Q4 24 | -22.7% | -91.8% | ||
| Q3 24 | -73.1% | -118.9% | ||
| Q2 24 | -90.9% | -111.0% | ||
| Q1 24 | -270.3% | -180.8% |
| Q4 25 | -17.0% | -73.9% | ||
| Q3 25 | -29.0% | -93.5% | ||
| Q2 25 | -2.6% | -73.9% | ||
| Q1 25 | -111.0% | -113.2% | ||
| Q4 24 | -23.7% | -122.4% | ||
| Q3 24 | -74.0% | -32.6% | ||
| Q2 24 | -91.8% | -58.8% | ||
| Q1 24 | -270.5% | -204.5% |
| Q4 25 | $-0.01 | $-0.22 | ||
| Q3 25 | $-0.02 | $-0.96 | ||
| Q2 25 | $0.00 | $-0.27 | ||
| Q1 25 | $-0.03 | $-0.39 | ||
| Q4 24 | $-0.01 | $-0.38 | ||
| Q3 24 | $-0.02 | $-0.12 | ||
| Q2 24 | $-0.02 | $-0.21 | ||
| Q1 24 | $-0.06 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.2M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $38.2M | $-33.9M |
| Total Assets | $74.2M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | $20.4M | ||
| Q3 25 | $5.7M | $22.7M | ||
| Q2 25 | $11.4M | $26.5M | ||
| Q1 25 | $15.9M | $13.0M | ||
| Q4 24 | $466.5K | $8.5M | ||
| Q3 24 | $220.4K | $11.3M | ||
| Q2 24 | $608.2K | $16.5M | ||
| Q1 24 | $948.1K | $4.0M |
| Q4 25 | $38.2M | $-33.9M | ||
| Q3 25 | $39.6M | $-26.7M | ||
| Q2 25 | $42.0M | $-19.4M | ||
| Q1 25 | $40.6M | $-34.4M | ||
| Q4 24 | $13.5M | $-25.9M | ||
| Q3 24 | $13.7M | $-20.4M | ||
| Q2 24 | $14.8M | $-25.3M | ||
| Q1 24 | $16.7M | $-36.0M |
| Q4 25 | $74.2M | $35.3M | ||
| Q3 25 | $69.6M | $36.5M | ||
| Q2 25 | $70.0M | $41.3M | ||
| Q1 25 | $63.5M | $28.6M | ||
| Q4 24 | $42.4M | $24.0M | ||
| Q3 24 | $39.0M | $27.5M | ||
| Q2 24 | $35.7M | $32.4M | ||
| Q1 24 | $35.2M | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.5M | $-2.5M |
| Free Cash FlowOCF − Capex | $-3.2M | $-2.5M |
| FCF MarginFCF / Revenue | -22.3% | -19.1% |
| Capex IntensityCapex / Revenue | 11.8% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-22.2M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.5M | $-2.5M | ||
| Q3 25 | $-7.5M | $-3.7M | ||
| Q2 25 | $-3.5M | $-7.3M | ||
| Q1 25 | $-6.1M | $-4.5M | ||
| Q4 24 | $-3.3M | $-5.7M | ||
| Q3 24 | $-2.5M | $-10.8M | ||
| Q2 24 | $-1.0M | $-13.4M | ||
| Q1 24 | $-2.7M | $-10.9M |
| Q4 25 | $-3.2M | $-2.5M | ||
| Q3 25 | $-8.2M | $-3.9M | ||
| Q2 25 | $-3.8M | $-7.4M | ||
| Q1 25 | $-7.0M | $-5.3M | ||
| Q4 24 | $-3.4M | $-5.8M | ||
| Q3 24 | $-4.2M | $-11.0M | ||
| Q2 24 | $-3.1M | $-13.5M | ||
| Q1 24 | $-2.8M | $-10.9M |
| Q4 25 | -22.3% | -19.1% | ||
| Q3 25 | -64.1% | -33.9% | ||
| Q2 25 | -37.7% | -66.1% | ||
| Q1 25 | -136.2% | -57.3% | ||
| Q4 24 | -41.7% | -69.7% | ||
| Q3 24 | -96.9% | -149.9% | ||
| Q2 24 | -69.5% | -183.1% | ||
| Q1 24 | -76.9% | -169.3% |
| Q4 25 | 11.8% | 0.3% | ||
| Q3 25 | 5.9% | 1.9% | ||
| Q2 25 | 3.2% | 0.8% | ||
| Q1 25 | 17.0% | 8.2% | ||
| Q4 24 | 1.5% | 0.6% | ||
| Q3 24 | 38.8% | 2.3% | ||
| Q2 24 | 46.8% | 0.8% | ||
| Q1 24 | 3.5% | 1.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SSII
| System Sales | $13.4M | 92% |
| Other | $1.2M | 8% |
TLSI
Segment breakdown not available.
